NORTHWEST BIOTHERAPEUTICS INC Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was $2.09M, a 134.91% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, conversion of convertible securities for the quarter ending 2026-03-31 was $226.00K, a 73.90% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, conversion of convertible securities for the quarter ending 2025-12-31 was $690.00K, a 86.49% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, conversion of convertible securities for the quarter ending 2025-09-30 was $353.00K, a 92.92% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, conversion of convertible securities for fiscal 2025 was $2.80M, a 80.15% decline from fiscal 2024.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, conversion of convertible securities for fiscal 2024 was $14.09M, a 25.50% decline from fiscal 2023.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, conversion of convertible securities for fiscal 2023 was $18.91M.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, conversion of convertible securities for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | $2.09M 10-Q · filed 2026-08-14 | $3.35M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $226.00K 10-Q · filed 2026-05-15 | $2.16M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $690.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $2.80M 10-K · filed 2026-04-15 |
| 2025-09-30 | $353.00K 10-Q · filed 2025-11-14 | $2.48M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $888.00K 10-Q · filed 2026-08-14 | $7.11M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $866.00K 10-Q · filed 2026-05-15 | $12.43M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $370.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $14.09M 10-K · filed 2026-04-15 |
| 2024-09-30 | $4.99M 10-Q · filed 2025-11-14 | $26.10M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $6.20M 10-Q · filed 2025-08-14 | $24.09M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $2.53M 10-Q · filed 2025-05-15 | $18.83M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $12.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $18.91M 10-K · filed 2025-03-31 |
| 2023-09-30 | $2.97M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $945.00K 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $2.62M 10-Q · filed 2024-05-10 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 10-K · filed 2020-03-16 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $855.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.56M derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 | $2.23M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-12-31 | $855.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $3.31M 10-K · filed 2020-03-16 |
| 2018-09-30 | $708.00K 10-Q · filed 2019-11-12 | $3.16M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $672.00K 10-Q · filed 2019-08-09 | $3.19M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $1.07M 10-Q · filed 2019-05-10 | $2.96M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $705.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02 | $1.89M 10-K · filed 2019-04-02 |
| 2017-09-30 | $736.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | |
| 2017-06-30 | $449.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | |
| 2017-03-31 | $2.00K 10-Q · filed 2018-05-16 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | $6.50M 10-K · filed 2017-04-17 |
| 2015-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | |
| 2001-12-31 | $31.58M 10-K · filed 2014-04-01 |